These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

702 related articles for article (PubMed ID: 31505066)

  • 21. Dupilumab: A Review in Chronic Rhinosinusitis with Nasal Polyps.
    Hoy SM
    Drugs; 2020 May; 80(7):711-717. PubMed ID: 32240527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis.
    Hirano I; Dellon ES; Hamilton JD; Collins MH; Peterson K; Chehade M; Schoepfer AM; Safroneeva E; Rothenberg ME; Falk GW; Assouline-Dayan Y; Zhao Q; Chen Z; Swanson BN; Pirozzi G; Mannent L; Graham NMH; Akinlade B; Stahl N; Yancopoulos GD; Radin A
    Gastroenterology; 2020 Jan; 158(1):111-122.e10. PubMed ID: 31593702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early and Long-Term Effects of Dupilumab Treatment on Circulating T-Cell Functions in Patients with Moderate-to-Severe Atopic Dermatitis.
    Bakker DS; van der Wal MM; Heeb LEM; Giovannone B; Asamoah M; Delemarre EM; Drylewicz J; Nierkens S; Boyman O; de Bruin-Weller MS; Thijs JL; van Wijk F
    J Invest Dermatol; 2021 Aug; 141(8):1943-1953.e13. PubMed ID: 33610558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dupilumab: First Global Approval.
    Shirley M
    Drugs; 2017 Jul; 77(10):1115-1121. PubMed ID: 28547386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dupilumab reduces local type 2 pro-inflammatory biomarkers in chronic rhinosinusitis with nasal polyposis.
    Jonstam K; Swanson BN; Mannent LP; Cardell LO; Tian N; Wang Y; Zhang D; Fan C; Holtappels G; Hamilton JD; Grabher A; Graham NMH; Pirozzi G; Bachert C
    Allergy; 2019 Apr; 74(4):743-752. PubMed ID: 30488542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug evaluation review: dupilumab in atopic dermatitis.
    Hamilton JD; Ungar B; Guttman-Yassky E
    Immunotherapy; 2015; 7(10):1043-58. PubMed ID: 26598956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Important roles of CD32 in promoting suppression of IL-4 induced immune responses by a novel anti-IL-4Rα therapeutic antibody.
    Zhao J; Jiang L; Deng L; Xu W; Cao Y; Chen C; Yang Y; Wu H; Huang Y; Zhu Z; Huang H
    MAbs; 2019 Jul; 11(5):837-847. PubMed ID: 30950681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Real-life effects of benralizumab on allergic chronic rhinosinusitis and nasal polyposis associated with severe asthma.
    Lombardo N; Pelaia C; Ciriolo M; Della Corte M; Piazzetta G; Lobello N; Viola P; Pelaia G
    Int J Immunopathol Pharmacol; 2020; 34():2058738420950851. PubMed ID: 32816558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spotlight on dupilumab in the treatment of atopic dermatitis: design, development, and potential place in therapy.
    D'Erme AM; Romanelli M; Chiricozzi A
    Drug Des Devel Ther; 2017; 11():1473-1480. PubMed ID: 28553077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of dupilumab for controlling severe atopic dermatitis with dominant-negative CARD11 variant.
    Charvet E; Bourrat E; Hickman G; Donadieu J; Bellanné-Chantelot C; Jachiet M; Bouaziz JD; Bagot M; Cassius C
    Clin Exp Dermatol; 2021 Oct; 46(7):1334-1335. PubMed ID: 33864281
    [No Abstract]   [Full Text] [Related]  

  • 31. Sustained clinical and histopathological remission in a patient with eosinophilic esophagitis and type-2 comorbidities at 18 months after discontinuation of dupilumab.
    González-Uribe V; Rodríguez-Bueno CPA; Mojica-González ZS; Malagón-Liceaga A; Basile-Alvarez MR
    Clin J Gastroenterol; 2024 Oct; 17(5):803-808. PubMed ID: 39046661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Asthma and Atopic Dermatitis: A Review of Targeted Inhibition of Interleukin-4 and Interleukin-13 As Therapy for Atopic Disease.
    Buzney CD; Gottlieb AB; Rosmarin D
    J Drugs Dermatol; 2016 Feb; 15(2):165-71. PubMed ID: 26885783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of dupilumab in perennial allergic rhinitis and comorbid asthma.
    Weinstein SF; Katial R; Jayawardena S; Pirozzi G; Staudinger H; Eckert L; Joish VN; Amin N; Maroni J; Rowe P; Graham NMH; Teper A
    J Allergy Clin Immunol; 2018 Jul; 142(1):171-177.e1. PubMed ID: 29355679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of polyphenols on allergic immune reactions: mechanisms of action.
    Magrone T; Jirillo E
    Proc Nutr Soc; 2012 May; 71(2):316-21. PubMed ID: 22369886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune modulation for treatment of allergic disease.
    Nguyen TH; Casale TB
    Immunol Rev; 2011 Jul; 242(1):258-71. PubMed ID: 21682751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Understanding the immune landscape in atopic dermatitis: The era of biologics and emerging therapeutic approaches.
    Moyle M; Cevikbas F; Harden JL; Guttman-Yassky E
    Exp Dermatol; 2019 Jul; 28(7):756-768. PubMed ID: 30825336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring the efficacy and contribution of Dupilumab in asthma management.
    Alsaffar RM; Alkholifi FK
    Mol Immunol; 2022 Jun; 146():9-17. PubMed ID: 35397375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma.
    Laidlaw TM; Bachert C; Amin N; Desrosiers M; Hellings PW; Mullol J; Maspero JF; Gevaert P; Zhang M; Mao X; Khan AH; Kamat S; Patel N; Graham NMH; Ruddy M; Staudinger H; Mannent LP
    Ann Allergy Asthma Immunol; 2021 May; 126(5):584-592.e1. PubMed ID: 33465455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The IL-13-OVOL1-FLG axis in atopic dermatitis.
    Furue K; Ito T; Tsuji G; Ulzii D; Vu YH; Kido-Nakahara M; Nakahara T; Furue M
    Immunology; 2019 Dec; 158(4):281-286. PubMed ID: 31509236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rosacea associated with dupilumab therapy.
    Heibel HD; Hendricks AJ; Foshee JP; Shi VY
    J Dermatolog Treat; 2021 Feb; 32(1):114-116. PubMed ID: 31132923
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.